USPTO serial 76143358
MPB
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- FRENCH, CURTIS W
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with MPB?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
MPB Cologne GmbH Molecular Plant & Protein Biotechnology
51063 Koln, DE
Other trademarks owned by MPB Cologne GmbH Molecular Plant & Protein Biotechnology
MPB Cologne GmbH Molecular Plant & Protein Biotechnology
51063 Koln, DE
Other trademarks owned by MPB Cologne GmbH Molecular Plant & Protein Biotechnology
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Steven J Hultquist
STEVEN J HULTQUIST INTELLECTUAL PROPERTY/TECHNOLOGY LAWP O BOX 14329RESEARCH TRIANGLE PARK, NC 27709-4329UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biochemicals, namely polynucleic acids, peptides, proteins, and antibodies for scientific, research and commercial use; genetically engineered biochemical for in vitro and in vivo scientific, research and commercial use including plant growth regulators, polypeptides, genes, enzymes, and polynucleic acids for agricultural use and to produce chemicals for research and commercial applications pertaining to chemistry, biochemistry, biology, bioreactors, agriculture, pharmaceuticals, diagnostics, medicine, bioremediation, decontamination, detoxification, food preservation; biochemicals produced by transgenic plants for use as pesticides, herbicides, fertilizers, perservatives, vitamins, proteins, polypeptides, enzymes, carbohydrates, and biopolymers | ACTIVE | — |
| 005 | Genetically engineered clinical and medical reagents, diagnostic preparations and reagents for clinical or medical laboratory use; medical diagnostic reagents; genetically engineered herbicides, pesticides, biopesticides, miticides, fungicides, bactericides and weed killers, all for domestic and agricultural uses; genetically engineered insecticides, vaccines for animal and human uses; vaccine adjuvants; hormones, proteins, peptides; and bactericidal proteins produced from transgenic plants for use as an agricultural bactericide | ACTIVE | — |
| 009 | Scientific laboratory equipment for analyzing chemical and biological syntheses, reactions and assays; scientific laboratory equipment to genetically engineer transgenic plants; separation or purification of gentically engineered products; and proliferation of genetically engineered transgenic plants | ACTIVE | — |
| 031 | Living plants, namely transgenic plants, such as potatoes; transgenic plant seed, such as rape seed | ACTIVE | — |
| 040 | Directed evolution services, namely the recombination of genes customized to the specification of others to produce gene sequences for use in science, research, chemistry, agriculture, medicine, and industry, such as vaccines, serum albumin, indicator proteins, proteins, peptides, polypeptides, biomaterials, transgenic plants and seeds, and diagnostic products including medical, environmental, food and non-food | ACTIVE | — |
| 042 | Chemical research services; scientific research services, research and testing services in the fields of genetic engineering of plants and plant cells to produce biochemical, such as polypeptides, protein products, metabolites or carbohydrates; research and development in the fields of fungal and bacterial resistant technology; research and product development for others in the field of genetically engineered plants and plant cells including transgenic plants; research and product development services in the fields of genetically engineered plants and plant cells including transgenic plants, genetics and gene therapy, botany, chemistry, pharmaceuticals, bioreactors, medical diagnostics, environmental diagnostic products, fungal and bacterial resistant technology, herbicides, pesticides, biopesticides, fungicides, bactericides, cytotoxic agents, bacteriology, virology, biocatalysis, metabolic pathways, and biochemical pathways | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by MPB Cologne GmbH Molecular Plant & Protein Biotechnology
- Other trademarks owned by MPB Cologne GmbH Molecular Plant & Protein Biotechnology
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 031
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named MPB
- Prosecution event ABN6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 14, 2003 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Aug 8, 2002 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Aug 5, 2002 | EXT1 | SOU EXTENSION 1 FILED | — |
| Aug 5, 2002 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 5, 2002 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Nov 13, 2001 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 24, 2001 | NPUB | NOTICE OF PUBLICATION | — |
| Jun 15, 2001 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 19, 2001 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 23, 2001 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Feb 21, 2001 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 15, 2001 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 12, 2001 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |